716 related articles for article (PubMed ID: 31558705)
1. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models.
Yang H; Feng R; Fu Q; Xu S; Hao X; Qiu Y; Feng T; Zeng Z; Chen M; Zhang S
Cell Death Dis; 2019 Sep; 10(10):718. PubMed ID: 31558705
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.
Yun YI; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Reger RL; Gregory CA; Choi H; Fulcher SF; Prockop DJ; Oh JY
Cytotherapy; 2017 Jan; 19(1):28-35. PubMed ID: 27840134
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: a pilot study.
Yang H; Aprecio RM; Zhou X; Wang Q; Zhang W; Ding Y; Li Y
PLoS One; 2014; 9(6):e100285. PubMed ID: 24979372
[TBL] [Abstract][Full Text] [Related]
4. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.
Soontararak S; Chow L; Johnson V; Coy J; Wheat W; Regan D; Dow S
Stem Cells Transl Med; 2018 Jun; 7(6):456-467. PubMed ID: 29635868
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells Promote Diabetic Corneal Epithelial Wound Healing Through TSG-6-Dependent Stem Cell Activation and Macrophage Switch.
Di G; Du X; Qi X; Zhao X; Duan H; Li S; Xie L; Zhou Q
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4344–4354. PubMed ID: 28810264
[TBL] [Abstract][Full Text] [Related]
7. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Wang D; Sun YQ; Gao WX; Fan XL; Shi JB; Fu QL
Cell Transplant; 2018 Sep; 27(9):1340-1351. PubMed ID: 30056763
[TBL] [Abstract][Full Text] [Related]
8. TSG-6 Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells Ameliorates DSS-induced colitis by Inducing M2 Macrophage Polarization in Mice.
Song WJ; Li Q; Ryu MO; Ahn JO; Ha Bhang D; Chan Jung Y; Youn HY
Sci Rep; 2017 Jul; 7(1):5187. PubMed ID: 28701721
[TBL] [Abstract][Full Text] [Related]
9. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice.
Song WJ; Li Q; Ryu MO; Ahn JO; Bhang DH; Jung YC; Youn HY
Stem Cell Res Ther; 2018 Apr; 9(1):91. PubMed ID: 29625582
[TBL] [Abstract][Full Text] [Related]
10. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.
Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY
Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473
[TBL] [Abstract][Full Text] [Related]
11. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds.
Qi Y; Jiang D; Sindrilaru A; Stegemann A; Schatz S; Treiber N; Rojewski M; Schrezenmeier H; Vander Beken S; Wlaschek M; Böhm M; Seitz A; Scholz N; Dürselen L; Brinckmann J; Ignatius A; Scharffetter-Kochanek K
J Invest Dermatol; 2014 Feb; 134(2):526-537. PubMed ID: 23921952
[TBL] [Abstract][Full Text] [Related]
12. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
13. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
[TBL] [Abstract][Full Text] [Related]
14. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH
Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868
[TBL] [Abstract][Full Text] [Related]
15. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis.
Wu HJ; Yiu WH; Li RX; Wong DW; Leung JC; Chan LY; Zhang Y; Lian Q; Lin M; Tse HF; Lai KN; Tang SC
PLoS One; 2014; 9(3):e90883. PubMed ID: 24646687
[TBL] [Abstract][Full Text] [Related]
17. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice.
Xu J; Wang X; Chen J; Chen S; Li Z; Liu H; Bai Y; Zhi F
Theranostics; 2020; 10(26):12204-12222. PubMed ID: 33204338
[No Abstract] [Full Text] [Related]
18. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
[TBL] [Abstract][Full Text] [Related]
19. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.
Zhao Q; Gregory CA; Lee RH; Reger RL; Qin L; Hai B; Park MS; Yoon N; Clough B; McNeill E; Prockop DJ; Liu F
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):530-5. PubMed ID: 25548183
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.
Kagia A; Tzetis M; Kanavakis E; Perrea D; Sfougataki I; Mertzanian A; Varela I; Dimopoulou A; Karagiannidou A; Goussetis E
Inflammation; 2019 Oct; 42(5):1730-1740. PubMed ID: 31227956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
